pending on the ability to respond to androgens. AIS is sub-classified into 3 clinical categories: complete (CAIS), partial (PAIS), and mild type (MAIS) . A mutation of the androgen receptor (AR) gene, located on the X chromosome (Xq11.2q12), is the only established molecular cause of AIS.
AR is a member of the steroid nuclear receptor subfamily of ligand-dependent transcriptional factors. It comprises an N-terminal domain (AR-NTD), a central DNA-binding domain (AR-DBD), and a ligand-binding domain (AR-LBD). AR interacts with a wide range of coregulator proteins, including epigenetic co-activators and components of the general transcription machinery. In the presence of an agonist, AR initiates a sequence of chromatin remodelling and histone modifications which promote transcriptional activation [Heemers and Tindall, 2007] . The AR-NTD is the least conserved domain as compared to other members of the steroid receptor family [McEwan, 2004] . It contains the ligand-independent activation function-1 (AF1). Two smaller transactivation units are also defined which are responsible for more than 50% AR-NTD activity: Tau-1 (amino acids 101-370) and Tau-5 (amino acids 360-528) [Jenster et al., 1995] . The AR-NTD has a disordered flexible structure and has so far resisted resolution by X-ray crystallography [Zhou et al., 2010] . Features unique to the AR-NTD are the glutamine (normal range 8-31) and glycine repeats (normal range 10-27) [Jääskeläinen, 2012] . As determined in vitro, variation of repeat length within the respective normal ranges affects AR transactivation activity [Kazemi-Esfarjani et al., 1995] .
The most frequent pathogenic AR gene defects are missense mutations, a large majority of which have been identified in the AR-LBD and AR-DBD (http://androgendb.mcgill.ca/) [Gottlieb et al., 2012] . The missense mutations identified to date in the AR-NTD are generally associated with milder clinical phenotypes [Gottlieb et al., 1999] . A possible explanation for this observation relates to the structural flexibility of the AR-NTD which may enable the AR to tolerate amino acid substitutions with little functional consequence. Pathogenic missense mutations within the AR-NTD would therefore provide a valuable tool to better define the structure-function relationship of this domain. Consequently, we have investigated 7 missense mutations and 2 insertion/deletion slippage mutations identified in our large database of patients with AIS who have proven AR mutations. This study aimed to define the pathogenicity for these AR-NTD mutants and to further understand the molecular function of the AR-NTD.
Patients and Methods

Subjects
All studies were conducted in accordance with approval of the local research ethics committee, and informed consent was obtained to use patient samples for diagnosis and the Disorders of Sex Development research program. Mutations Q120E, G216R, G248V, L272F, del57L (Q57L), and ins58L (Q58L) ( table 1 ) were from the Cambridge DSD database. A159T, N235K, and P380R were also reported previously [Giwercman et al., 2001; Audi et al., 2010] .
Plasmid Constructs
An AR cDNA construct pSVAR0 [Brinkmann et al., 1989] and 2 luciferase reporter constructs, pGRE2-TATA-Luc [Knoke et al., 1999] and pPEM-Luc [Barbulescu et al., 2001 ], have previously been described. Renilla luciferase construct pRL-TK (Promega) was used as a control. Missense mutations and del57L were introduced into pSVAR0 using a QuikChange XL site-directed mutagenesis kit (Stratagene). Ins58L was generated by routine PCR, and the AR -fragment was cloned into pSVAR0 via pGEM-T Easy (Promega). The AR cDNA was fully sequenced for verification.
Transactivation Assays
A volume of 1.25 × 10 5 /well COS-1 cells (American Type Culture Collection) were seeded into 12-well tissue culture plates in Dulbecco's modified essential medium (DMEM) containing 2 m M glutamine and 10% charcoal-stripped serum. After 24 h, cells were transiently transfected with 25 ng pSVAR0 or the vector encoding the mutation, 500 ng either pGRE2-TATA-Luc or pPEM-Luc, and 25 ng pRL-TK. Lipofectin transfection reagent (Invitrogen) was used with Opti-MEM (Invitrogen) according to the manufacturer's instructions. A volume of 0-10 nmol/l dihydrotestosterone (DHT; Sigma) was added to the cells 16 h after transfection. Twenty-four hours after the addition of the hormone, the cells were harvested in 500 μl lysis buffer (25 m M glycylglycine pH 7.8, 15 m M MgSO 4 , 4 m M EGTA, 1 m M dithiothreitol, and 1% Triton X), and the ratio of firefly to Renilla luciferase was measured with reagents from Nanolight technology using a Centro/Centro XS3 Microplate Luminometer LB 960 (Berthold Technologies). For Flp-In 293 cell transfection (Invistrogen), 2 × 10 5 cells/well were seeded and were transfected after 48 h with 500 ng pGRE2-TATA-Luc and 25 ng pRL-TK, using Lipofectin with Opti-MEM. Harvest and transactivation assay procedures were the same as previously described.
Western Blot
A total of 20 μg of whole cell extract was analysed by SDS-PAGE and transferred to an Immobilon-P membrane (Millipore). The blot was probed with primary rabbit anti-AR antibody (Sc-816, Santa Cruz), followed by anti-rabbit horseradish peroxidaseconjugated secondary antibodies (Dako) and visualised with ECL Blotting Detection reagent (GE Healthcare). After Western blotting, the membranes were stained with 0.5% Ponceau S in 1% acetic acid to confirm equal protein transfer.
Generation of Mutant AR Stably Expressed in HEK293 Cell Lines
Wild-type and mutant AR (ins58L, del57L) were subcloned into the recombination vector pcDNA5/FRT using Kpn I and Nhe I sites. Flp-In 293 cells were cultured in DMEM, 10% FBS, glutamine, Pen-Strep, and 100 μg/ml Zeocin. A volume of 2 × 10 6 cells were plated in 60-mm tissue culture dishes 48 h prior to transfection. Cells were transfected with 4 ml of Opti-MEM containing 0.8 μg pcDNA5/FRT-AR exchange plasmid, 7.2 μg Flp recombinase expression plasmid pOG44, and 20 μl Lipofectamine 2000. After 48 h, the cells were split into dishes and cultured in DMEM, 10% FBS, glutamine, Pen-Strep, and 200 μ M HygromycinB (Invitrogen). Individual colonies were transferred on day 10. Zeocin sensitivity at 100 μg/ml was tested in each cell line to verify FRT-sitespecific integration of the receptor.
Protein Expression and Purification
Bacterial expression vectors pET-AR4 and pGEX-AR4 containing the human AF1 domain of the AR (amino acids 142-485) were used [Reid et al., 2002a] . Mutations A159T, N235K, and G248V were introduced into the vectors using a QuikChange sitedirected mutagenesis kit and verified by direct sequencing. AR-AF1 proteins were purified as described previously [Lavery and McEwan, 2008] . Proteins were assessed for purity by SDS-PAGE and scanning of stained gels using Image J (NIH).
Intrinsic Fluorescence Emission Spectroscopy
Fluorescence measurements were made using a Shimadzu 1501 spectrofluorimeter with excitation and emission band width of 10 nm using a 1-cm path-length cuvette. The fluorescence spectra of AR-AF1 mutants were generated at excitation wavelengths of 278 and 295 nm and emission wavelengths read between 300 and 450 nm. Folded and unfolded profiles of the proteins were also measured using trimethylamine N-oxide (TMAO; Sigma) and urea (Sigma). Histidine tagged proteins (25 μg) were prepared both in 200 μl dialysis buffer [Lavery and McEwan, 2008] and another dialysis buffer with 2 M TMAO or 3 M urea. Samples were measured in duplicate. All spectra were corrected for contributions of the buffer and solutes. 
Partial Proteolysis Analysis
Histidine and GST-tagged AF1 proteins (50 pmol) were diluted in proteolysis buffer [Lavery and McEwan, 2008] or proteolysis buffer with 2 M TMAO. The proteins were treated with 6 ng trypsin (Roche), 6 ng chymotrypsin (Roche), and 50 ng endoproteinase GluC (New England Biolabs) over a series of time points at room temperature. Reactions were stopped by addition of 5× SDS-PAGE sample buffer. Samples were heated at 75 ° C for 5 min, were resolved by SDS-PAGE on a 12.5% gel, and fragments were analysed by Coomassie staining. For analysis, gels were dried on 3MM filter paper and scanned. Protein bands on the digitised image were analysed using the Image J program.
Statistical Analysis
A t test was used to assess differences between groups as indicated in the text. Differences were considered significant at p ≤ 0.05.
Results
Transactivation Activity of AR-NTD Mutants
Transcriptional activity of the missense mutations was examined using the GRE ( fig. 1 A) and the Pem promoter ( fig. 1 B) . Western blotting verified similar cellular levels for mutant and wild-type receptor ( fig. 1 C) . GRE promoter activity was reduced about 20% for Q120E relative to wild-type levels at 1 n M and 10 n M DHT, respectively. Q120E showed normal activity when measured under the Pem promoter. A159T, N235K, and G248V exhibited a statistically significant loss-of-function phenotype, responding with only ∼ 60% of wild-type AR activity in the Pem -luciferase reporter in response to DHT (10 n M ). Interestingly, for these 3 mutations, no significant difference in the transactivation function in response to DHT as compared to wild-type AR was detected using the GRE -luciferase reporter. Similarly, the L272F mutation showed a non-significant reduction ( ∼ 15%, p = 0.371) in DHT responsiveness under the Pem -luciferase reporter as compared to wild-type AR, but no functional deficit was detected for L272F using the GRE-luciferase reporter. In contrast, the P380R mutation reduced DHT-induced transactivation significantly ( ∼ 20%) relative to the wild type for the GRE-luciferase reporter (DHT, 10 n M ) and the Pem-luciferase at both 1 and 10 n M DHT.
Function and Expression of Slippage Mutations
The mutations del57L and ins58L are located in a stretch of 4 leucines immediately N-terminal of the AR polyglutamine repeat. The AR mRNA sequence encoding these 4 leucines (5 ′ -UUGCUGCUGCUG-3 ′ ) complements the AR mRNA sequence encoding the polyglutamine repeat (5 ′ -CAGCAGCAGCAA-3 ′ ), and both are believed to form a stable RNA stem structure [Yeap et al., 2004] . We hypothesised that insertion of an additional leucine codon may stabilise this AR stem-loop structure with the pathologic effect of hindering ribosome movement, translational accuracy or transcriptional/translational efficiency, resulting in a decreased AR protein synthesis. Conversely, this model would predict that deletion of a leucine codon would shorten the stem, potentially reducing its stability, but would not negatively impact on AR synthesis. To test functionality, we introduced the mutations ins58L and del57L into pSVAR0, and HEK293 cell lines stably expressing these mutants or wild-type AR were generated. Western blotting showed a lower protein level for ins58L relative to the wild type ( fig. 2 A) . Multiple (n = 5) independent expressing clones were tested, and the results were reproducible. Consistent with our model, expression of del57L was similar to the wild-type protein. Transactivation activity of ins58L was 70% of the wild-type (p < 0.05) with DHT at 1 and 10 n M . del57L had an almost identical activity as the wildtype protein ( fig. 2 B) . The results indicate that ins58L has a reduced transactivation activity relative to the wild type and to del57L.
Protein Structure Analysis Using Intrinsic Fluorescence Emission Spectroscopy
Intrinsic fluorescence emission spectroscopy was used to further evaluate the effects of mutations on the structure of the AR-NTD. Recombinant protein fragments of the wild-type AR-AF1 subdomain of the AR-NTD and AR-AF1 containing the A159T, N235K, and G248V mutations were purified. Wild-type AR-AF1 is composed of 22-26% α-helices, 5-12% β-strands, and 64-69% random coils, and 3 helical regions were predicted [Reid et al., 2002a; Kumar et al., 2004] . Structure prediction analysis for A159T suggested a partial disruption of the first β-strand. N235K is located in the second α-helix and is predicted to have no effect on the helical structure but may disrupt the following β-strand. G248V is located between the second and third α-helix and may impact on the local structure. Intrinsic fluorescence emission spectroscopy was performed on proteins in their native state, a folded state induced by TMAO, and an unfolded state induced by urea. TMAO has been found to promote a natural folded structure for polypeptides that have a disordered structure [Kumar et al., 2004] . Intrinsic fluorescence emission spectra for tyrosine and tryptophan residues were measured using an excitation wavelength of 278 nm ( fig. 3 ) . The excitation wavelength 295 nm measured only the steady-state emission for tryptophan. AR-AF1 contains 13 tyrosine residues and 2 tryptophan residues. The spectrum provides information on the local conformation surrounding these residues. At an excitation of 278 nm, the wildtype AR-AF1 and the mutants showed the same emission maximum at 343 nm due to the tryptophan residues and a shoulder at 309 nm due to tyrosine emission. In the presence of TMAO, the tryptophan emission maximum (λmax) blue-shifted to 338 nm, and the shoulder due to tyrosine emission was lost for all the proteins. This indicates that the tryptophan residues become less exposed to the solvent in the presence of TMAO, consistent with AR-AF1 developing a more structured conformation. Treatment with urea caused the opposite effect on all 4 proteins, the peak spectra red-shifted to 347 nm, resulting from the tryptophan residues becoming more solvent-exposed. The measurement at an excitation of 295 nm showed a similar trend (data not shown).
Partial Proteolysis
The local structure of wild-type AR-AF1 protein and the mutants were analysed by partial proteolysis, using the enzymes trypsin, chymotrypsin, and endoproteinase GluC (Endo-GluC). Cleavage of AR-AF1 was investigated in the presence or absence of TMAO. Figure 4 B shows an example of the Endo-GluC digestion. Endo-GluC cleaves at 23 sites, some of which are closer to the mutated amino acid residues compared to trypsin or chymotrypsin cleavage sites ( fig. 4 A) . The digestion rates of all proteins were reduced in the presence of TMAO compared to experiments lacking TMAO. This is consistent with stabilisation and the adoption of a more folded composition of AR-AF1 in the presence of TMAO. However, no qualitative or quantitative difference was observed between the wild-type and mutant proteins in the presence or absence of TMAO. Steady-state fluorescence emission spectra of wild-type and mutant AF1 domains (A159T, N235K, and G248V) in A dialysis buffer after excitation at 278 nm, B 2 M TMAO, and C 3 M urea. Intrinsic fluorescence of tyrosine and tryptophan residues was measured using an excitation wavelength of 278 nm. D Summary of the emission maximum (λmax) of wild-type and mutant AF1 domains in native, folded, and unfolded states. 
Discussion
It was well established that the N-and C-terminal domains of the AR play cooperative and independent roles in androgen signalling [Jääskeläinen et al., 2006] , yet the precise molecular function of the AR-NTD remains poorly understood. In general, non-selective hormone responsive elements are more dependent on N-C interactions as compared to selective elements. Therefore, alterations within the AR-NTD are likely to have a more significant effect on non-selective response elements. Within the AR-NTD, amino acid sequence alignment analysis between species has revealed 3 highly conserved regions: residues 1-30, 224-258, and 500-541 [He et al., 2004; McEwan, 2004] . The first 30 amino acids include the 23 FQNLF 27 motif, important for N-C interaction [Jääskeläinen et al., 2006] . The region also interacts with MAGE-11, a bridging protein that stabilises co-activator interaction with AF2 [Bai et al., 2005] . Experimental studies indicated that RAP74 interacts with amino acids 224-258. AR activity and interaction with RAP74 decreased by 60% as a consequence of a mutation of 3 residues within this domain [Betney and McEwan, 2003 ]. The spontaneous somatic AR mutations A236T and E238G (human numbering) identified in the TRAMP mouse prostate cancer model showed elevated levels of ligand-independent basal activity. E238G exhibited increased responsiveness to co-activators ARA160 and ARA70 and decreased interaction with the COOH-terminus of the Hsp70-interacting protein, a negative regulator of the AR [Han et al., 2001; He et al., 2004] .
The detailed structure-activity insights obtained from pathogenic AR mutations identified in the AR-LBD and AR-DBD are currently limited for the AR-NTD. For this reason, we investigated 7 missense mutations and 2 insertion/deletions located in the AR-NTD in patients with AIS. The phenotypes associated with A159T, N235K, G248V, P380R, del57L, and ins58L are mild to partial forms of AIS. Mutations Q120E and L272F were associated with a more severe phenotype, and the patients were raised female. Interestingly, G216R was associated with a range of phenotypic variations manifested within the same family [Deeb et al., 2005] .
Different response elements have previously been shown to influence AR activity [Reid et al., 2001] . The androgen-response elements in the Pem promoter are selective, and the levels of induction from the Pem promoter are lower than that observed for the promiscuous MMTV or GRE reporters. Furthermore, optimal nuclear receptor function is dependent upon accurate inter-domain communication [Helsen et al., 2012] which can be influenced by allosteric mechanisms [Watson et al., 2013] . Therefore, these amino acid substitutions have identified structural domains within the AR, which play important roles in the recognition and response to distinct androgen-response elements. For this reason, the transactivation activity of identified AR-NTD mutations was tested using 2 AR-regulated luciferase reporters. Reduced Pemluciferase reporter activity was observed for A159T, N235K, G248Vl, and P380R as compared to wild-type AR; the loss of function was greater than that detected using the GRE -luciferase promoter. These results suggest a greater sensitivity of the Pem promoter to detect AR mutant dysfunction as previously reported [Zuccarello et al., 2008] . Furthermore, based on the Pem -luciferase reporter activity, it is likely that A159T, N235K, G248V, and P380R are pathogenic. Ala159 is located close to the PSTLSL motif which interacts with RAP74, the large component of TFIIF [Reid et al., 2002b] . Asn235 and Gly248 are located in a region highly conserved across species. Asn235 is unique to humans, being a serine residue in other mammalian species. A change to lysine (N235K) introduces a structurally distinct charged polar side chain as compared to serine or asparagine. This dramatic change is probably an important feature contributing to the loss of AR function. P380R showed a 20% decrease in transactivation on both promoters. Pro380 is the penultimate C-terminal residue of the 8-proline-stretch in the Tau-5 region of the AR-NTD. This proline repeat is highly conserved and, similar to other such repeats, may be a unique feature of intrinsically disordered regions [Simon and Hancock, 2009] .
We performed protein structure analyses on mutations A159T, N235K, and G248V. Although these mutations are associated with severe functional defects, no significant structural differences were detected between the wild-type and the mutant AR-AF1 using fluorescence and limited proteolysis methods. This suggests the AR-NTD can structurally tolerate such amino acid substitutions within the generally disordered structural arrangement of the AR-NTD, indicating that the loss of function observed in transactivation assays is not simply due to a change in the structure or folding of AF1. The results are consistent with the known flexible nature of the AF1 structure.
Missense mutations, identified in patients with severe AIS, showed normal or modest deficits in AR transactivation as compared to wild-type AR under the conditions employed. Q120E displayed an ∼ 20% decreased activity using the GRE -luciferase reporter promoter detectable with DHT (1 n M ), although this did not reach statistical significance. Consistently, this mutation was inherited via the maternal grandfather, suggesting that Q120E has a minimal pathogenic effect in this patient. Wild-type activity was detected for G216R using both Pem and GRE reporters. This mutation was identified in 6 patients from 3 different families; in 1 consanguineous family, 3 of 4 affected members were raised as female. This phenotypic variation suggests an involvement of other factors that may affect the degree of undervirilisation in patients harbouring the G216R mutation. Examples include fetal testosterone concentrations, co-regulator function, and secondary 5α-reductase deficiency [Boehmer et al., 2001] . It is also possible that a second mutation contributes to the sex reversal in these families, as has been recently described [Idkowiak et al., 2010] .
Functional analysis of the ins58L mutation revealed a reduced expression as compared to the wild type. Transcriptional activity for ins58L was ∼ 30% lower than the wild-type AR in the stable cell lines. This suggests that ins58L is pathogenic and the likely cause of AIS. Further studies are required to define the molecular mechanism leading to a reduced AR-ins58L synthesis. Possible causes include reduced rates of transcription and/or translation, mRNA instability, or elevated rates of mutant receptor degradation. A family with AIS was reported with mutations in the Kozak and protein-coding (E2K) regions of the AR locus which resulted in reduced AR protein levels in transient expression studies [Choong et al., 1996a] . Expansion of the AR polyglutamine repeat associated with decreased AR activity has also been linked to reduced AR expression [Choong et al., 1996b] . However, the relationship between AR expression and disease phenotype remains poorly understood. For example, the hypomorphic mouse has an MAIS phenotype with normal male genital development, even though levels of AR expression are markedly reduced. It is possible that elevated testosterone levels rescue AR function [Arango et al., 1999] . The observation may reflect differences in the developmental role of androgens in mice and humans. In contrast, the expression levels and transactivation activity of del57L were similar to wild-type AR in HEK293 cells in this study. This mutation (described as L57Q) was recently reported to show loss of function in transfection studies using COS-7 cell lines [Hay and McEwan, 2012] . The discrepant results using different cellular assays may be explained by its environment, including factors such as intrinsic AR co-regulator levels.
The del57L and ins58L mutations have also been reported previously. ins58L was identified in 2 subjects with MAIS, identified in a cohort of infertile males [Lund et al., 2003] . It was also found in human prostate cancer specimens and is a common variant in tumours developed in the humanised exon-1 mouse model of prostate cancer [O'Mahony et al., 2008] . del57L has been reported as a somatic mutation in a number of different cancer types, including prostate cancer [Tilley et al., 1996; Yeh et al., 2007] . However, the frequency of such in-frame insertions and deletions needs to be established in larger unaffected populations.
In conclusion, this study has illustrated that the detection of mild molecular defects due to AR-NTD mutations can be assay-dependent. Assay sensitivity may depend on the cell line, ligand, and promoter construct used [Simon and Mueller, 2006; Werner et al., 2006] . For this reason, we suggest that 2 or more promoters are used to test the function of the mutations ( Pem /TAT-GRE , probasin/ MMTV), and the use of a second cell line should be considered (COS-1/PC-3, COS-1/HeLa). Probasin and PSA promoters may be a choice if the mutation involves N-C interaction [He et al., 2002] . Cell lines also differ in their AR co-regulator complement and ability to metabolise natural androgens during the assay incubation period [Bebermeier et al., 2006] . Commonly used cell lines such as COS-1, HeLa, and PC-3 are poor activators of complex promoters such as the PSA promoter, suggesting the coregulator environment is not optimal for androgen-dependent gene activation. Therefore, new assays for measuring mutant AR function are required. Future developments may involve utilisation of recombinase-mediated cassette exchange (RMCE) or clustered regularly interspaced short palindromic repeats (CRISPR) technology to express mutant receptors and reporters in androgenresponsive lines relevant to sex development. This may allow the use of reporter gene assays in isogenic cell lines that contain the appropriate co-regulator complexes with androgen-regulated reporters in the appropriate chromatin and epigenetic contexts. Such assays may thus more closely reflect the endogenous gene environment and provide more detailed insights in the subtle functional roles of identified AR-NTD mutations.
